原发性免疫缺陷疾病患者的疫苗接种

A. Khalili
{"title":"原发性免疫缺陷疾病患者的疫苗接种","authors":"A. Khalili","doi":"10.18502/IGJ.V3I4.7453","DOIUrl":null,"url":null,"abstract":"Primary Immunodeficiency Disorders (PID), are heterogeneous groups of an abnormality in innate and adoptive immune systems. Patients with these disorders, are susceptible to life threatening infections. Infection control, is an important strategy for improving the quality of life and prognosis. Prophylaxis, intravenous immunoglobulin and antibiotic therapy for a long period of time, is an appropriate option for many patients with PID. But vaccination in immunocompromised patients may play a significant role and various outcomes. Depending on the type of PID, there are different results after the administration of vaccines in patients. In some cases, immune response is perfect and there is a well protection against the syndromes. On the other hand, in some other patients, immune response is impaired, and the vaccination is ineffective or even could lead to severe overwhelming side effects. To date, there are no well established guidelines about the vaccination of immunocompromised people. In this review, we are going to describe the latest recommendations for the immunization of patients with PID, based on the published literatures.","PeriodicalId":406184,"journal":{"name":"Immunology and Genetics Journal","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vaccination in Patients with Primary Immunodeficiency Disorders\",\"authors\":\"A. Khalili\",\"doi\":\"10.18502/IGJ.V3I4.7453\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Primary Immunodeficiency Disorders (PID), are heterogeneous groups of an abnormality in innate and adoptive immune systems. Patients with these disorders, are susceptible to life threatening infections. Infection control, is an important strategy for improving the quality of life and prognosis. Prophylaxis, intravenous immunoglobulin and antibiotic therapy for a long period of time, is an appropriate option for many patients with PID. But vaccination in immunocompromised patients may play a significant role and various outcomes. Depending on the type of PID, there are different results after the administration of vaccines in patients. In some cases, immune response is perfect and there is a well protection against the syndromes. On the other hand, in some other patients, immune response is impaired, and the vaccination is ineffective or even could lead to severe overwhelming side effects. To date, there are no well established guidelines about the vaccination of immunocompromised people. In this review, we are going to describe the latest recommendations for the immunization of patients with PID, based on the published literatures.\",\"PeriodicalId\":406184,\"journal\":{\"name\":\"Immunology and Genetics Journal\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology and Genetics Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/IGJ.V3I4.7453\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Genetics Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/IGJ.V3I4.7453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

原发性免疫缺陷疾病(PID)是先天性和过继性免疫系统异常的异质群体。患有这些疾病的患者容易受到危及生命的感染。感染控制,是提高生活质量和预后的重要策略。预防,静脉注射免疫球蛋白和长期抗生素治疗,是许多PID患者的适当选择。但免疫功能低下患者的疫苗接种可能发挥重要作用和各种结果。根据PID的类型不同,患者接种疫苗后的结果也不同。在某些情况下,免疫反应是完美的,对综合症有很好的保护。另一方面,在其他一些患者中,免疫反应受损,疫苗接种无效,甚至可能导致严重的压倒性副作用。迄今为止,关于免疫功能低下人群的疫苗接种尚无完善的指导方针。在这篇综述中,我们将根据已发表的文献描述PID患者免疫接种的最新建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Vaccination in Patients with Primary Immunodeficiency Disorders
Primary Immunodeficiency Disorders (PID), are heterogeneous groups of an abnormality in innate and adoptive immune systems. Patients with these disorders, are susceptible to life threatening infections. Infection control, is an important strategy for improving the quality of life and prognosis. Prophylaxis, intravenous immunoglobulin and antibiotic therapy for a long period of time, is an appropriate option for many patients with PID. But vaccination in immunocompromised patients may play a significant role and various outcomes. Depending on the type of PID, there are different results after the administration of vaccines in patients. In some cases, immune response is perfect and there is a well protection against the syndromes. On the other hand, in some other patients, immune response is impaired, and the vaccination is ineffective or even could lead to severe overwhelming side effects. To date, there are no well established guidelines about the vaccination of immunocompromised people. In this review, we are going to describe the latest recommendations for the immunization of patients with PID, based on the published literatures.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信